Somerset, N.J. (PRWEB) April 14, 2015
Catalent Pharma Solutions (Booth 1546), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that the company will officially launch an extension to its ADVASEPT™ technology platform at the Interphex conference, which takes place at the Javits Center, New York, on April 21st – 23rd, 2015.
ADVASEPT is an advanced aseptic filling solution for biologics, parenteral, respiratory, and other products. ADVASEPT features a glass-free primary packaging container that reduces, and even eliminates, many of the main concerns associated with traditional glass vials, such as contamination with foreign or glass particulates, and surface delamination.
Catalent will showcase a broad range of its delivery technologies and solutions designed to increase bioavailability and drug efficacy, including the particle size engineering capabilities added with the acquisition of Micron Technologies in November 2014.
Catalent has also announced a full agenda of speaker presentations to be given by company experts and executives, including:
- Tuesday, April 21, 2015, 10.00 a.m. – 10.45 a.m.
Kay Schmidt, Vice President of R&D, Advanced Delivery Technologies, will take part in a panel discussion at the Interphex Live event on the subject of “Leveraging QbD as a CMO Market Strategy for Client Success”;
- Tuesday, April 21, 2015, 12.00 p.m. – 1.30 p.m.
Bill Hartzel, Director, Strategic Execution, Advanced Delivery Technologies, will take part in a round table discussion in the BioProcess International Theatre, entitled, “Deciding on Single-Use vs Stainless Steel Bioprocessing Strategy: What do CMOs know that the Biopharma’s don’t?”;
- Wednesday, April 22, 2015, 1.30 p.m. – 1.55 p.m.
Bill Hartzel returns to the BioProcess International Theatre to present “Reducing the risk associated with the filling of biologics with advanced aseptic processing”;
- Wednesday, April 22, 2015, 2.15 p.m. – 3.00 p.m.
Scott Gunther, Vice President of Quality, Advanced Delivery Technologies, will be a panelist at the Pharma and Biopharma Outsourcing Association (PBOA) roundtable on Quality Agreements;
- Thursday, April 23, 2015, 10.00 a.m. – 10.45 a.m.
Mike Valazza, Vice President of Business Development, Advanced Delivery Technologies, will take part in a panel discussion at the Interphex Live event, entitled, “Technology Transfer’s Role in the Lifecycle Management of a Product”.
For further information or to arrange a meeting with a Catalent executive at the show, please contact Ed Dutton at edward(at)nepr(dot)eu
For further information on the Interphex conference visit http://www.interphex.com
Notes for Editors
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at 30 facilities across 5 continents, and in fiscal 2014 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com
More products. Better treatments. Reliably supplied.™